UNSPSC 51384512: Losmiprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H15ClO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GRY6X9550R, chemically known as propionic acid, 2-(3-(p-chlorobenzoyl)-o-tolyloxy)- but generally known as losmiprofen, which bears US NIH Compound Identifier 68922. European Medicines Agency schedules Losmiprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08596MIG.

UNSPSC 51384512 Losmiprofen, a Commodity code, shows minimal relevant recent procurement activity in state and local markets. The code nominally describes a specific nonsteroidal anti-inflammatory drug (NSAID), but the single recent opportunity tagged under it—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, products entirely outside the scope of losmiprofen pharmaceutical supply. This mismatch suggests either a misclassification in the county's tagging system or a data artifact, and does not reflect genuine demand for losmiprofen under this code tier in state or local procurement.

The Seminole County opportunity, posted June 30, 2026 with a response deadline of July 26, 2023, requests 1,900 units of naloxone and 800 drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement requires E-Verify compliance, drug-free workplace certification, and various insurance coverages; potential FEMA funding introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. Based on available data, this code does not support a material pipeline of state and local losmiprofen solicitations, and firms pursuing pharmaceutical supply contracts should focus upstream on broader pharmaceutical commodity codes rather than rely on this specific Commodity classification.